Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
significance » significantly (Expand Search)
Showing 2,201 - 2,220 results of 16,674 for search '(( significance ((level decrease) OR (mean decrease)) ) OR ( significant increase decrease ))', query time: 0.65s Refine Results
  1. 2201
    Mst1 knockout or suppressing its kinase activity increases the production of inflammatory mediators by activating the NF-κB pathway.

    Mst1 knockout or suppressing its kinase activity increases the production of inflammatory mediators by activating the NF-κB pathway. by Jianyang Li (461703)

    Published 2024
    Save to List
    Saved in:
  2. 2202
    HPLC chromatogram of standard 6-gingerol (0.2 mg/mL) (a), 6-shogaol (0.2 mg/mL) (b), ginger extract obtained by conventional maceration (c), and ginger extract obtained by pulsed electric field extraction (d).

    HPLC chromatogram of standard 6-gingerol (0.2 mg/mL) (a), 6-shogaol (0.2 mg/mL) (b), ginger extract obtained by conventional maceration (c), and ginger extract obtained by pulsed e... by Hataichanok Chuljerm (19144293)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2203
    Total phenolic content (TPC) and total flavonoid content (TFC) in ginger extract obtained from conventional maceration and pulsed electric field extraction.

    Total phenolic content (TPC) and total flavonoid content (TFC) in ginger extract obtained from conventional maceration and pulsed electric field extraction. by Hataichanok Chuljerm (19144293)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2204
    Graphical abstract_6-Shogaol ginger.

    Graphical abstract_6-Shogaol ginger. by Hataichanok Chuljerm (19144293)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2205
    The percentage of DPPH<sup>•</sup> (A) and ABTS<sup>•+</sup> (B) inhibition of 6-shogaol-rich ginger extract and Trolox.

    The percentage of DPPH<sup>•</sup> (A) and ABTS<sup>•+</sup> (B) inhibition of 6-shogaol-rich ginger extract and Trolox. by Hataichanok Chuljerm (19144293)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2206
    Transcriptome and Metabolome Based Mechanisms Revealing the Accumulation and Transformation of Sugars and Fats in Pinus armandii Seed Kernels during the Harvesting Period

    Transcriptome and Metabolome Based Mechanisms Revealing the Accumulation and Transformation of Sugars and Fats in Pinus armandii Seed Kernels during the Harvesting Period by Nan Li (155066)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 2207
    Chronic morphine exposure and withdrawal alters resulting proportions of lineage-specific midbrain progenitor cell fates.

    Chronic morphine exposure and withdrawal alters resulting proportions of lineage-specific midbrain progenitor cell fates. by Rhea Sullivan (18824253)

    Published 2025
    Save to List
    Saved in:
  8. 2208
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2209
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2210
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2211
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2212
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2213
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2214
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2215
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2216
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2217
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2218
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2219
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2220
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: